Table 1.
Patient characteristics (n = 28 patients)
| Baseline characteristics | |
| Median age (SD), years | 61 (11.9) |
| Male | 10 (36) |
| White | 27 (96) |
| Ethnicity (Hispanic) | 3 (11) |
| Clinical characteristics | |
| Karnofsky performance status | |
| 60 | 1 (4) |
| 70 | 4 (14) |
| 80 | 8 (29) |
| 90 | 7 (25) |
| 100 | 8 (29) |
| Baseline B symptoms | 15 (54) |
| Bone marrow involvement | 12 (43) |
| Prior transplant history | 1 (4) |
| Tumor bulk >5 cm | 7 (25) |
| Elevated β2-microglobulin | 11 (39) |
| FLIPI | |
| 0 | 1 (4) |
| 1 | 4 (14) |
| 2 | 10 (36) |
| 3 | 8 (29) |
| 4 | 5 (18) |
| FLIPI-2 | |
| 0 | 4 (14) |
| 1 | 9 (32) |
| 2 | 8 (29) |
| 3 | 5 (18) |
| 4 | 2 (7) |
| Prior chemotherapy regimens | |
| 0 | 0 (0) |
| 1 | 16 (57) |
| 2 | 7 (25) |
| 3 | 3 (11) |
| 4 | 2 (7) |
| Response to prior chemotherapy regimens | |
| CR | 9 (32) |
| PR | 4 (14) |
| SD | 1 (4) |
| PD | 11 (39) |
| UK | 3 (11) |
Values are n (%) unless otherwise indicated. CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; UK, unknown.